 [Free Beacon] Congressional Democrats pushing for an ethics probe into a Trump cabinet nominee’s stock trades have their own histories of investing in sectors of the economy they oversee, public records show.
Senate Minority Leader Chuck Schumer (D., N.Y.) last week called for an investigation into stock trades by Rep. Tom Price (R., N.C.), who President-elect Donald Trump has tapped to lead the Department of Health and Human Services.
Schumer and Senate Democrats are focusing on Price’s stock portfolio and trading history, which has included holdings in a number of health and insurance companies.
"We don’t know if he broke the law, but there are certainly enough serious questions to warrant an investigation before any hearing is held on Congressman Price to become secretary of HHS," Schumer said at a press conference last week.
Senate Democrats’ strategy on the Price nomination is part of a larger focus on alleged conflicts of interest among Trump cabinet nominees. However, unlike a number of those nominees Price’s personal financial information is publicly available due to reporting requirements for members of Congress.
At issue are 40 trades in health industry companies worth more than $300,000. Schumer and Sens. Patty Murray (D., Wash.) and Ron Wyden (D., Ore.), the ranking Democrats on the Health and Finance Committees, respectively, want to put Price’s nomination on hold pending an investigation into those trades and whether they coincided with legislation written or supported by Price.
That strategy could open up Senate Democrats to criticism, as Schumer, Wyden, and Democratic members of the Finance and Health Committees, which will both hold confirmation hearings for Price next week, have also traded in industries they oversee.
Schumer himself owned securities that likely benefitted from policies he advanced in his official capacity. 
|
